Kymera Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Kymera Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2021 to Q3 2024.
  • Kymera Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 753 %, a 18.7% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 753 +119 +18.7% Sep 30, 2024
Q2 2024 690 +77.1 +12.6% Jun 30, 2024
Q1 2024 656 +102 +18.5% Mar 31, 2024
Q4 2023 595 +78 +15.1% Dec 31, 2023
Q3 2023 634 +139 +28.1% Sep 30, 2023
Q2 2023 613 +109 +21.6% Jun 30, 2023
Q1 2023 554 +87.6 +18.8% Mar 31, 2023
Q4 2022 517 +97.6 +23.3% Dec 31, 2022
Q3 2022 495 +129 +35.2% Sep 30, 2022
Q2 2022 504 +205 +68.7% Jun 30, 2022
Q1 2022 466 Mar 31, 2022
Q4 2021 419 Dec 31, 2021
Q3 2021 366 Sep 30, 2021
Q2 2021 299 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.